Media Category: Treatments

16th of June 2020, Fifth ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised for the first time an interactive and fully digital learning experience. Here you can review the full webinar on Biomarkers in Ms & Epidemiology of MS. ABSTRACTSBIOMARKERS IN MSNIKOLAOS GRIGORIADISMultiple Sclerosis is an autoimmune, multifactorial disorder with its main hallmarks the persistent neuroinflammation and chronic neurodegeneration. Despite its extensive study, the lack of reliable and specific biomarkers for the disease makes it...

16th of June 2020, Fifth ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised for the first time an interactive and fully digital learning experience. Here you can review the full webinar on Progressive Forms of Multiple Sclerosis. Abstracts :CARLO POZZILLI AND BART VAN WIJMEERSCHMultiple Sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) and causes neurological impairment and disability. Progressive MS (PMS) is characterized by a continuous clinical deterioration without recovery....

16th of June 2020, Fifth ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised for the first time an interactive and fully digital learning experience. Here you can review the full webinar on NMO spectrum disorders. Abstracts :NIKOLAOS GRIGORIADISDiagnostic errors may still common in Multiple Sclerosis (MS). In a number of cases where T2 lesions are identified in MRI may be considered as MS lesions resulting in inappropriate, sometimes harmful therapeutic interventions for the patient. Mono- or multi-focal symptoms consistent...

14th of March 2019, Fourth ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised an interactive learning and networking experience. Here you can review one of the two lectures that were on the agenda. ABSTRACTProf Ralf Ziemssen gave an introduction and his perspective on real world data in MS. What is it and why is it so important to collect them. And how real world evidence complements clinical trial data. TJALF ZIEMSSENProfessor Tjalf Ziemssen is Director of the Center of Clinical Neuroscience with its Multiple Sclerosis...

14th of March 2019, Fourth ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised an interactive learning and networking experience. Here you can review one of the two workshops that were on the agenda. ABSTRACTMagnetic resonance imaging (MRI) plays a central role in the diagnosis and follow-up of MS patients. Prof Nicola De Stefano talked very practically about what neurologists need while using MRI as an important tool. NICOLA DE STEFANONicola De Stefano is full Professor of Neurology at the Department of  Medicine,...

22th of March 2018, Third ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised an interactive learning and networking experience. Here you can review one of the three lectures that were on the agenda: Lifestyle in MS ABSTRACTThere is a complicated, bi-directional relation between lifestyle factors and multiple sclerosis (MS). Several studies examined the relationship between these factors and the development and/or worsening of MS, since better understanding of this relationship may pave the ways for possible preventive strategies....

9th of March 2017, second ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised an interactive learning and networking experience. Here you can review one of the three lectures that were on the agenda: Suboptimal Response on Treatment. ABSTRACTWhat is it? How to do prognoses on and of treatment? When to change a treatment? CELIA OREJA-GUEVARAProfessor Celia Oreja-Guevara is appointed ViceChair of Neurology and Head of Multiple Sclerosis Center of the University Hospital San Carlos,Madrid (Spain), where she also serves as Senior...

17th of March 2016, first ParadigMS Symposium. The ParadigMS Foundation and the Belgian Study Group for Multiple Sclerosis (BSGMS) organised an interactive learning and networking experience. Here you can review one of the three lectures that were on the agenda: Disease modifying treatment and management. ABSTRACTProf van Wijmeersch prepared this presentation in collaboration with Prof Paolo Gallo. Prof Van Wijmeersch presented a number of highlights in the treatment and management of relapsing remitting MS. More specifically, he focused on:Early treatment of RRMS, how to choose when...